American Century Companies’s Dianthus Therapeutics DNTH Stock Holding History

American Century Companies's DNTH Position: Q2 2026 in Review

American Century Companies increased its Dianthus Therapeutics (DNTH) stake by 11% in Q2 2026, buying an estimated $765K and bringing the position to 87,860 shares worth $8.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1634.

American Century Companies first reported a position in DNTH in Q1 2024 and has held it in 10 quarters since. 244 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

• American Century Companies held 87,860 shares of Dianthus Therapeutics worth $8.56M as of Q2 2026.
• American Century Companies bought 8,764 Dianthus Therapeutics shares in Q2 2026, an estimated $765K.
• Dianthus Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1634 holding.
• American Century Companies first reported a position in Dianthus Therapeutics in Q1 2024 and has held it in 10 quarters since.
• 244 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.